Jabra Enhance Select 300 vs Signia Pure C&G IX

The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 out of 65 OTC hearing aids tested, placing it in the top 25% of its category. In our standardized testing, speech clarity in quiet environments stands out as a notable strength, scoring 3.6/5—a solid result that sits 0.85 points above the category average. Feedback handling is excellent at 5.0/5, meaning users should experience stable performance without whistling during typical wear. Own-voice comfort also performs well at 3.5/5, nearly a full point above average, which can contribute to a more natural listening experience. Speech understanding in noisy environments presents a limitation, scoring 1.5/5—essentially at the category average but low in absolute terms. This is a common challenge across OTC devices, though users seeking strong noise performance may want to compare alternatives. Music streaming scores 2.6/5, which is above the category average by 0.68 points but mixed in absolute quality. The Enhance Select 300 offers rechargeable batteries and streaming compatibility with both iPhone and Android devices, along with hands-free functionality. It has earned Expert's Choice Awards in both 2023 and 2024. Shoppers in this price range should note that alternatives like the Lucid Tala and Audicus Omni 2 score higher overall, while options like the Jabra Enhance Pro 20 at Costco offer similar sound quality at a lower price point. This device is best suited for those prioritizing speech clarity in quieter settings and stable, feedback-free performance.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.